PTC Therapeutics
PTCT
#3089
Rank
A$7.65 B
Marketcap
A$91.67
Share price
-2.68%
Change (1 day)
-20.79%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): A-$1.97

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$1.94. In 2025 the company made an earnings per share (EPS) of A$13.04 an increase over its 2024 EPS that were of A-$7.02.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.97-115.09%
2025A$13.04-285.84%
2024A-$7.02
2022A-$11.564.85%
2021A-$11.02
2019A-$6.6366.17%
2018A-$3.9929.33%
2017A-$3.09-50.12%
2016A-$6.19-17.59%
2015A-$7.5157.63%
2014A-$4.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.79-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$23.25-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.33 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A-$3.90 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A-$1.56-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A-$6.20 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA